WXE-25798-59072 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-08
Dose 1 — Pfizer-BioNTech
2021-04-29
Dose 2 — Pfizer-BioNTech
2021-12-17
Dose 3 — Moderna
2021-12-18
Registered in v-safe
2021-12-18
Survey response — days 1–6 daily, dose 3
MedDRA: Decreased appetite, Helplessness — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Loss of appetite, feelings of helplessness

MedDRA releases: 2024-11 · check-in free text available
2021-12-20
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-12-22
Survey response — days 1–6 daily, dose 3
MedDRA: Oropharyngeal pain — Feeling: Fair

Free text: Sore throat

MedDRA releases: 2024-11 · check-in free text available
2022-01-03
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-08	Pfizer-BioNTech	No
2	2021-04-29	Pfizer-BioNTech	No
3	2021-12-17	Moderna	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-18

Systemic reaction (other): Loss of appetite, feelings of helplessness

2021-12-22

Systemic reaction (other): Sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Decreased appetite	·	·	✓
SRO	Helplessness	·	·	✓
SRO	Oropharyngeal pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release